“…Aptamers have been developed which bind small organic molecules (Hirao et al, 1997;Babendure et al, 2003;Sazani et al, 2004;Chu et al, 2006;Liu and Lu, 2006), proteins (Ruckman et al, 1998;Jayasena, 1999;Srisawat and Engelke, 2001; Lee et al, 2004), heavy metal ions (Chang et al, 2005;Swearingen et al, 2005;Wrzesinski and Ciesiolka, 2005;Stefan et al, 2006;Wernette et al, 2007) and even viruses (Gopinath et al, 2006a,b). Aptamers are best known as ligands to proteins, rivaling antibodies in both affinity and specificity (Jayasena, 1999), and aptamer-based therapeutics are now emerging (Ruckman et al, 1998).…”